CG
IMGN

Cutler Group’s Immunogen Inc IMGN Stock Holding History

Cutler Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,900
Closed -$115K – 3956
2023
Q4 		$115K Buy
3,900
+3,300
+550% +$65.7K 0.01% 1002
2023
Q3 		$9K Buy
600
+100
+20% +$1.66K ﹤0.01% 2561
2023
Q2 		$9K Buy
+500
New +$5.9K ﹤0.01% 2337
2023
Q1 		– Sell
-27,472
Closed -$117K – 4973
2022
Q4 		$136K Buy
27,472
+7,613
+38% +$41.3K 0.01% 996
2022
Q3 		$94K Buy
19,859
+11,759
+145% +$62K 0.01% 1436
2022
Q2 		$36K Buy
8,100
+4,400
+119% +$19.1K ﹤0.01% 2207
2022
Q1 		$17K Buy
+3,700
New +$20.5K ﹤0.01% 3223
2021
Q4 		– Sell
-1,000
Closed -$6.21K – 6343
2021
Q3 		$5K Hold
1,000
– – ﹤0.01% 4520
2021
Q2 		$6K Buy
+1,000
New +$6.98K ﹤0.01% 4367
2019
Q2 		– Sell
-14,400
Closed -$39K – 4944
2019
Q1 		$39K Buy
+14,400
New +$62.4K ﹤0.01% 1602
2018
Q2 		– Sell
-9,344
Closed -$98K – 5076
2018
Q1 		$98K Buy
9,344
+7,550
+421% +$74.6K 0.01% 1196
2017
Q4 		$11K Sell
1,794
-2,584
-59% -$15.9K ﹤0.01% 3073
2017
Q3 		$33K Sell
4,378
-7,290
-62% -$48.4K ﹤0.01% 2658
2017
Q2 		$82K Buy
11,668
+1,368
+13% +$6.26K ﹤0.01% 2038
2017
Q1 		$39K Sell
10,300
-4,798
-32% -$14K ﹤0.01% 2657
2016
Q4 		$30K Sell
15,098
-8,600
-36% -$17.3K ﹤0.01% 3066
2016
Q3 		$63K Buy
23,698
+9,100
+62% +$26.5K ﹤0.01% 2234
2016
Q2 		$44K Buy
14,598
+11,321
+345% +$71K ﹤0.01% 2491
2016
Q1 		$27K Buy
+3,277
New +$27.7K ﹤0.01% 2977

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cutler Group's IMGN Position: Q1 2024 in Review

Cutler Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 3,900 shares — an estimated $115K sold.

Cutler Group first reported a position in IMGN in Q1 2016 and held it in 19 quarters. The position peaked at $136K in Q4 2022. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Cutler Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 3,900 Immunogen Inc shares in Q1 2024, an estimated $115K.
  • Cutler Group first reported a position in Immunogen Inc in Q1 2016 and held it in 19 quarters.
  • Cutler Group's Immunogen Inc position peaked at $136K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.